ProQR Therapeutics NV (PRQR)
1.95
+0.12
(+6.56%)
USD |
NASDAQ |
May 31, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Cash from Operations (Quarterly): -16.44M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -16.44M |
| December 31, 2023 | -5.928M |
| September 30, 2023 | -8.231M |
| June 30, 2023 | -10.55M |
| March 31, 2023 | 48.04M |
| December 31, 2022 | -21.20M |
| September 30, 2022 | -13.44M |
| June 30, 2022 | -14.65M |
| March 31, 2022 | -22.97M |
| December 31, 2021 | 4.356M |
| September 30, 2021 | -8.932M |
| June 30, 2021 | -12.03M |
| March 31, 2021 | -14.17M |
| December 31, 2020 | -12.46M |
| September 30, 2020 | -13.21M |
| June 30, 2020 | -11.52M |
| March 31, 2020 | -16.56M |
| December 31, 2019 | -13.63M |
| September 30, 2019 | -9.487M |
| June 30, 2019 | -12.07M |
| March 31, 2019 | -14.04M |
| Date | Value |
|---|---|
| December 31, 2018 | -11.10M |
| September 30, 2018 | -4.477M |
| June 30, 2018 | -6.142M |
| March 31, 2018 | -11.93M |
| December 31, 2017 | -8.739M |
| September 30, 2017 | -10.35M |
| June 30, 2017 | -11.14M |
| March 31, 2017 | -9.356M |
| December 31, 2016 | -7.856M |
| September 30, 2016 | -11.83M |
| June 30, 2016 | -9.623M |
| March 31, 2016 | -8.568M |
| December 31, 2015 | -7.489M |
| September 30, 2015 | -7.032M |
| June 30, 2015 | -6.418M |
| March 31, 2015 | -5.952M |
| December 31, 2014 | -6.668M |
| September 30, 2014 | -5.458M |
| June 30, 2014 | -4.448M |
| March 31, 2014 | -2.652M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.97M
Minimum
Mar 2022
48.04M
Maximum
Mar 2023
-9.253M
Average
-12.26M
Median
Cash from Operations (Quarterly) Benchmarks
| uniQure NV | -60.58M |
| Merus NV | -44.39M |
| argenx SE | -- |
| Pharming Group | -7.647M |
| Pharvaris NV | -26.32M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -19.26M |
| Cash from Financing (Quarterly) | -0.4551M |
| Free Cash Flow | -43.28M |
| Free Cash Flow Per Share (Quarterly) | -0.2112 |
| Free Cash Flow to Equity (Quarterly) | -17.20M |
| Free Cash Flow to Firm (Quarterly) | -17.23M |
| Free Cash Flow Yield | -27.34% |